Search research articles
Contact Us
Filters
Showing results (151-160 of 202) with videos related to
Page
of 21
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Can severe vincristine neurotoxicity be prevented?
Z R Desai, H W Van den Berg, J M Bridges, et al.
British Journal of Clinical Pharmacology
|
September 1, 1993
The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man
T C Tham, J P McKaigue, S Guy, et al.
British Journal of Clinical Pharmacology
|
March 29, 2012
The assessment of β-adrenoceptor blocking drugs in hyperthyroidism
S G Carruthers, A Ghosal, D G McDevitt, et al.
The Journal of Pharmacy and Pharmacology
|
May 1, 1996
Circadian variation of alpha 1-adrenoceptor-mediated pressor response to phenylephrine in man
T C Tham, S Guy, J G Riddell, et al.
Postgraduate Medical Journal
|
January 1, 1977
Comparison of the effects of lignocaine and mexiletine on experimental ventricular arrhythmias
J D Allen, J G Kelly, R G James, et al.
British Journal of Clinical Pharmacology
|
June 1, 1984
Differential blockade of alpha-adrenoceptors by indoramin
D P Nicholls, P C O'Connor, D W Harron, et al.
British Medical Journal
|
April 21, 1973
Duration of action of beta-blocking drugs
S G Carruthers, J G Kelly, D G McDevitt, et al.
American Heart Journal
|
January 1, 1974
Adrenaline-induced lignocaine-resistant dysrhythmias in experimental myocardial infarction
J D Allen, R G James, B T McNamee, et al.
Acta Ophthalmologica Scandinavica
|
May 20, 1998
Tackling the "dropped nucleus"
S Stenkula, E Byhr, S Crafoord, et al.
British Journal of Clinical Pharmacology
|
March 1, 1980
A comparison of mexiletine and a slow release formulation of mexiletine in patients admitted to a coronary care unit [proceedings]
D M Boyle, C Chapman, C Kinney, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 202) with videos related to
Sort By:
Page
of 21
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Can severe vincristine neurotoxicity be prevented?
Z R Desai, H W Van den Berg, J M Bridges, et al.
British Journal of Clinical Pharmacology
|
September 1, 1993
The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man
T C Tham, J P McKaigue, S Guy, et al.
British Journal of Clinical Pharmacology
|
March 29, 2012
The assessment of β-adrenoceptor blocking drugs in hyperthyroidism
S G Carruthers, A Ghosal, D G McDevitt, et al.
The Journal of Pharmacy and Pharmacology
|
May 1, 1996
Circadian variation of alpha 1-adrenoceptor-mediated pressor response to phenylephrine in man
T C Tham, S Guy, J G Riddell, et al.
Postgraduate Medical Journal
|
January 1, 1977
Comparison of the effects of lignocaine and mexiletine on experimental ventricular arrhythmias
J D Allen, J G Kelly, R G James, et al.
British Journal of Clinical Pharmacology
|
June 1, 1984
Differential blockade of alpha-adrenoceptors by indoramin
D P Nicholls, P C O'Connor, D W Harron, et al.
British Medical Journal
|
April 21, 1973
Duration of action of beta-blocking drugs
S G Carruthers, J G Kelly, D G McDevitt, et al.
American Heart Journal
|
January 1, 1974
Adrenaline-induced lignocaine-resistant dysrhythmias in experimental myocardial infarction
J D Allen, R G James, B T McNamee, et al.
Acta Ophthalmologica Scandinavica
|
May 20, 1998
Tackling the "dropped nucleus"
S Stenkula, E Byhr, S Crafoord, et al.
British Journal of Clinical Pharmacology
|
March 1, 1980
A comparison of mexiletine and a slow release formulation of mexiletine in patients admitted to a coronary care unit [proceedings]
D M Boyle, C Chapman, C Kinney, et al.
Page
of 21